Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • Glenmark appoints...

    Glenmark appoints Yasir Rawjee as CEO of Glenmark Life Sciences

    Medical Dialogues BureauWritten by Medical Dialogues Bureau Published On 2019-05-08T09:15:52+05:30  |  Updated On 18 Aug 2021 6:40 AM GMT

    Yasir Rawjee joins Glenmark Life Sciences from Mylan, where most recently he was the Head of Global API Operations, Glenmark Pharmaceuticals said in a BSE filing.


    New Delhi: Glenmark Pharmaceuticals Tuesday announced the appointed of Yasir Rawjee as the Chief Executive Officer (CEO) of Glenmark Life Sciences, its subsidiary for the active pharmaceuticals ingredients (API) business.


    Rawjee joins Glenmark Life Sciences from Mylan, where most recently he was the Head of Global API Operations, Glenmark Pharmaceuticals said in a BSE filing.


    Read Also: Glenmark expands specialty portfolio with OTIPRIO co-promotion agreement with Otonomy


    "Glenmark Pharmaceuticals, a research-led global integrated pharmaceutical company, announces that it has appointed Yasir Rawjee as the Chief Executive Officer of Glenmark Life Sciences, its subsidiary for the API business," it said.


    Rawjee, a PhD in Chemistry from Texas A&M University, USA, and B Sc (Tech.) from UDCT Mumbai has over 25 years of experience in the pharmaceutical industry, it said.


    "We are happy that Rawjee will now spearhead the API unit and take it to greater heights with his rich experience both in the technical and marketing aspects of the business," said Glenn Saldanha, Chairman and Managing Director, Glenmark Pharmaceuticals.


    Read Also: Glenmark launches SGLT2 Inhibitor Remogliflozin under brand names Remo, Remozen


    Glenmark's API business has witnessed a robust growth rate of 15 per cent CAGR over the last five years while maintaining its leadership position globally across several molecules, the company said.


    To provide a strategic focus to this business, Glenmark had earlier this year transferred the API business to a wholly-owned subsidiary Glenmark Life Sciences, it said.


    "We see significant growth potential in our API business given the increasing demand for good quality and sustained supply of APIs globally. With this view, we housed our API business into a separate subsidiary, which will be run independently," Saldanha said.

    https://pubads.g.doubleclick.net/gampad/ads?iu=/21687779244/clinicalkey_video_ad&description_url=[placeholder]&tfcd=0&npa=0&sz=640x480&gdfp_req=1&output=vast&unviewed_position_start=1&env=vp&impl=s&correlator=

    Read Also: Glenmark gets Russian Healthcare Ministry nod for nasal spray Momate Rhino


    Glenmark Life Sciences has built strong partnerships across the globe and has a very focused approach to further expand the API business, said Rawjee.

    active pharmaceuticals ingredients API B Sc BSE CAGR CEO chemistry chief executive officer Glenmark Glenmark life sciences Glenmark Pharma Glenmark Pharmaceuticals Glenn Saldanha Head of Global API Operations Mylan New Delhi UDCT Mumbai Yasir Rawjee yasir rawjee glenmark 
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier

      This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:

      Search only trustworthy HONcode health websites:

      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2020 Minerva Medical Treatment Pvt Ltd

      © 2020 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      X